World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
105
Citations
44402
World Ranking
584
National Ranking
348

Medicine

D-Index
106
Citations
45784
World Ranking
6472
National Ranking
3441

Robert B. Nussenblatt publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Robert B. Nussenblatt sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 600 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Robert B. Nussenblatt D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert B. Nussenblatt sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 105 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Robert B. Nussenblatt was a researcher affiliated with the National Institutes of Health in the United States. Their work primarily concentrated in the field of Medicine, with a strong focus on Ophthalmology, contributing to 25 publications in this subfield. Other areas of study included Epidemiology, Rheumatology, Oncology, and Radiology, Nuclear Medicine and Imaging.

The scientist's research centered on several main topics, notably:

  • Ocular Diseases and Behçet's Syndrome
  • Retinal and Optic Conditions
  • Retinal Diseases and Treatments
  • Ocular Infections and Treatments
  • Intraocular Surgery and Lenses
  • IgG4-Related and Inflammatory Diseases
  • Autoimmune and Inflammatory Disorders

Nussenblatt published frequently in the following venues:

  • American Journal of Ophthalmology
  • Ophthalmology
  • BMJ Oncology
  • Ocular Immunology and Inflammation
  • British Journal of Ophthalmology

Recent papers reflected a focus on ocular conditions and immunosuppression, with notable titles including:

  • Exudative Retinal Detachment in Ocular Inflammatory Diseases: Risk and Predictive Factors (2020), American Journal of Ophthalmology
  • Risk of Cataract in Intermediate Uveitis (2021), American Journal of Ophthalmology
  • Incidence of and Risk Factors for Cataract in Anterior Uveitis (2023), American Journal of Ophthalmology
  • Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality (2023), Ophthalmology
  • Use of immunosuppression and subsequent cancer incidence: cohort study (2023), BMJ Oncology

Their collaboration network included frequent coauthors such as Eric B. Suhler, John H. Kempen, Grace A. Levy-Clarke, Jennifer E. Thorne, and Nirali Bhatt, each contributing to multiple joint publications.

Best Publications

  • Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

    Douglas A Jabs;Robert B Nussenblatt;James T Rosenbaum

  • Standardizing immunophenotyping for the Human Immunology Project

    Holden T. Maecker;J. Philip McCoy;Robert Nussenblatt

  • TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1

    Ahjoku Amadi-Obi;Cheng-Rong Yu;Xuebin Liu;Rashid M Mahdi

  • Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel

    Douglas A. Jabs;James T. Rosenbaum;C.Stephen Foster;Gary N. Holland

  • International Uveitis Study Group Recommendations for the Evaluation of Intraocular Inflammatory Disease

    Etienne Bloch-Michel;Robert B. Nussenblatt

  • Standardizatlon of Vitreal inflammatory Activity in Intermediate and Posterior Uveitis

    Robert B. Nussenblatt;Alan G. Palestine;Chi-Chao Chan;François Roberge

  • Uveitis: Fundamentals and Clinical Practice

    Robert B. Nussenblatt;Scott M. Whitcup

  • The natural history of uveitis.

    Robert B. Nussenblatt

  • An Unusually High Prevalence of Ocular Toxoplasmosis in Southern Brazil

    Peter D. Glasner;Claudio Silveira;Deanna Kruszon-Moran;Maria C. Martins

  • Cutting Edge: NKT Cells Constitutively Express IL-23 Receptor and RORγt and Rapidly Produce IL-17 upon Receptor Ligation in an IL-6-Independent Fashion

    Aleksandra V. Rachitskaya;Anna M. Hansen;Reiko Horai;Zhuqing Li

  • Renal histopathologic alterations in patients treated with cyclosporine for uveitis.

    Alan G. Palestine;Howard A. Austin;James E. Balow;Tatjana T. Antonovych

  • Chapter 3 Retinal specific antigens and immunopathogenic processes they provoke

    I. Gery;M. Mochizuki;R.B. Nussenblatt

  • Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen.

    Robert B. Nussenblatt;Kamal K. Mittal;Stephen Ryan;W. Richard Green

  • Ophthalmic Involvement in Acquired Immunodeficiency Syndrome

    Alan G. Palestine;Merlyn M. Rodrigues;Abe M. Macher;Chi-Chao Chan

  • Ocular therapeutic agent delivery devices and methods for making and using such devices

    Michael R. Robinson;Karl G. Csaky;Robert B. Nussenblatt;Janine A. Smith

  • Cyclosporin a Therapy in the Treatment of Intraocular Inflammatory Disease Resistant to Systemic Corticosteroids and Cytotoxic Agents

    Robert B. Nussenblatt;Alan G. Palestine;Chi-Chao Chan

  • Epidemiology and Course of Disease in Childhood Uveitis

    Janine A. Smith;Friederike Mackensen;H. Nida Sen;Julie F. Leigh

  • Methotrexate for Ocular Inflammatory Diseases

    Sapna Gangaputra;Sapna Gangaputra;Craig W. Newcomb;Teresa L. Liesegang;R. Oktay Kaçmaz

  • Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen.

    R B Nussenblatt;R R Caspi;R Mahdi;C C Chan

  • Macular thickening and visual acuity. Measurement in patients with cystoid macular edema.

    Robert B. Nussenblatt;Steven C. Kaufman;Alan G. Palestine;Matthew D. Davis

Frequent Co-Authors

Chi-Chao Chan
Chi-Chao Chan National Institutes of Health
Douglas A. Jabs
Douglas A. Jabs Johns Hopkins University School of Medicine
Jennifer E. Thorne
Jennifer E. Thorne Johns Hopkins University
James T. Rosenbaum
James T. Rosenbaum Oregon Health & Science University
C. Stephen Foster
C. Stephen Foster Harvard University
Igal Gery
Igal Gery National Institutes of Health
Rubens Belfort
Rubens Belfort Federal University of Sao Paulo
Rachel R. Caspi
Rachel R. Caspi National Institutes of Health
Janet L. Davis
Janet L. Davis University of Miami
Frederick L. Ferris
Frederick L. Ferris National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their knowledge beyond immunology, exploring related healthcare fields can open numerous opportunities. Nursing, in particular, offers various pathways that complement immunology expertise, especially in patient care and clinical research.

Many individuals transition into nursing through online BSN programs for non nurses, which are designed for those without prior nursing backgrounds. These programs provide foundational nursing skills while accommodating busy schedules.

If you are looking for a quicker route into nursing, consider easiest accelerated nursing programs to get into, allowing students to fast-track their education and enter the workforce sooner.

For those interested in practical nursing roles, exploring easy admission LPN programs can be a great way to gain hands-on experience and build a healthcare career.

Advanced practice roles like nurse practitioners are also accessible through easiest NP program options, which provide pathways to specialized and leadership roles within healthcare settings, often integrating immunology applications in patient treatment and research.

Best Scientists Citing Robert B. Nussenblatt

Recently Published Articles